The ESTIV Members AreaThe new Biomedical research report from ECVAM is out: https://ec.europa.eu/jrc/en/science-update/tackling-neurodegenerative-diseases-more-human-relevant-research.
3 May 2021
The new Biomedical research report from ECVAM: Tackling neurodegenerative diseases with more human relevant research
Related content
ESTIV Best Abstract Award at the VHP 2026 Conference
The award, valued at €300, will recognise an outstanding abstract in the field of in silico toxicology and New Approach Methodologies (NAMs).
Special Issue completed – ESTIV 2024: The Application of New Approach Methodologies (NAMs) in Drug Discovery and Drug and Chemical Safety Assessment
ESTIV would like to extend its heartfelt thanks to all contributors to this special issue, which highlights some of the science and activities that took place during the congress.
ESTIV 2026 LAST-MINUTE ABSTRACT SUBMISSION OPEN
We are pleased to announce that last‑minute poster abstract submissions are now open.
Researchers who still wish to contribute are warmly invited to submit their work. The deadline for last‑minute submissions is 8 May 2026 at 23:59 CET.
Silver Sponsor
Corporate Members
Communication partners
Memorandum of Understanding
